Article Versions Notes

Wada H, Shiraki K, Matsumoto T, Suzuki K, Yamashita Y, Tawara I, Shimpo H, Shimaoka M. A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab. Journal of Clinical Medicine. 2022; 11(20):6142. https://doi.org/10.3390/jcm11206142

Wada, Hideo, Katsuya Shiraki, Takeshi Matsumoto, Kei Suzuki, Yoshiki Yamashita, Isao Tawara, Hideto Shimpo, and Motomu Shimaoka. 2022. "A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab" Journal of Clinical Medicine 11, no. 20: 6142. https://doi.org/10.3390/jcm11206142

Wada, H., Shiraki, K., Matsumoto, T., Suzuki, K., Yamashita, Y., Tawara, I., Shimpo, H., & Shimaoka, M. (2022). A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab. Journal of Clinical Medicine, 11(20), 6142. https://doi.org/10.3390/jcm11206142